These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 10930937)

  • 1. Legal pitfalls in the diagnosis of prostate cancer.
    Dunn IB; Kirk D
    BJU Int; 2000 Aug; 86(3):304-7. PubMed ID: 10930937
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prostatic punch biopsy].
    Braun M; Engelmann U
    Aktuelle Urol; 2006 Jul; 37(4):291-302. PubMed ID: 16897646
    [No Abstract]   [Full Text] [Related]  

  • 3. Can we stop ordering prostate-specific antigen screening tests?
    Katz MH
    JAMA Intern Med; 2013 May; 173(10):847-8. PubMed ID: 23588841
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of prostate specific antigen and prostate specific antigen density in the diagnosis of prostate cancer in a community based urology practice.
    Rommel FM; Agusta VE; Breslin JA; Huffnagle HW; Pohl CE; Sieber PR; Stahl CA
    J Urol; 1994 Jan; 151(1):88-93. PubMed ID: 7504748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prostate-specific antigen testing in france.
    Braillon A
    JAMA Intern Med; 2013 Nov; 173(21):2014. PubMed ID: 24276059
    [No Abstract]   [Full Text] [Related]  

  • 6. Prostate-specific antigen testing for prostate cancer: the case for informed consent.
    McCredie M; Cox B
    Med J Aust; 1998 Jul; 169(1):9-10. PubMed ID: 9695692
    [No Abstract]   [Full Text] [Related]  

  • 7. Why I will continue to screen prostate-specific antigen for myself and other appropriate men.
    Keller DL
    JAMA Intern Med; 2014 Jan; 174(1):164. PubMed ID: 24394929
    [No Abstract]   [Full Text] [Related]  

  • 8. Knowledge, attitude and practice regarding prostate specific antigen (PSA) and prostate biopsy.
    Nazim SM; Raza SJ; Ather MH
    J Coll Physicians Surg Pak; 2013 Jul; 23(7):529-30. PubMed ID: 23823969
    [No Abstract]   [Full Text] [Related]  

  • 9. Biopsy diagnosis of prostatic cancer--current areas of concern.
    Feneley MR; Parkinson MC
    J Clin Pathol; 1997 Apr; 50(4):265-6. PubMed ID: 9215135
    [No Abstract]   [Full Text] [Related]  

  • 10. Why I will continue to screen prostate-specific antigen for myself and other appropriate men--reply.
    Katz MH
    JAMA Intern Med; 2014 Jan; 174(1):164. PubMed ID: 24394931
    [No Abstract]   [Full Text] [Related]  

  • 11. Informed consent for prostate-specific antigen testing.
    Gann PH
    Urology; 2003 Jan; 61(1):5-6. PubMed ID: 12559253
    [No Abstract]   [Full Text] [Related]  

  • 12. Informed consent for prostate-specific antigen screening.
    Wilkinson S; Chodak G
    Urology; 2003 Jan; 61(1):2-4. PubMed ID: 12559252
    [No Abstract]   [Full Text] [Related]  

  • 13. [Legal problems in everyday urology].
    Denis B
    Prog Urol; 1997 Apr; 7(2):297-300. PubMed ID: 9264777
    [No Abstract]   [Full Text] [Related]  

  • 14. Informed consent for prostate-specific antigen-based screening--European view.
    Ito K; Schrder FH
    Urology; 2003 Jan; 61(1):20-2. PubMed ID: 12559259
    [No Abstract]   [Full Text] [Related]  

  • 15. It ain't what you do, it's the way you do it: five golden rules for transforming prostate-specific antigen screening.
    Vickers A; Carlsson S; Laudone V; Lilja H
    Eur Urol; 2014 Aug; 66(2):188-90. PubMed ID: 24411991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Re: Billis et al.: Does the type of prostatic atrophy influence the association of extent of atrophy in needle biopsies and serum prostate-specific antigen levels? (Urology 2009;74:1111-1115).
    Papatsoris A; Albanis S; Deliveliotis C
    Urology; 2010 May; 75(5):1239; author reply 1240. PubMed ID: 20451754
    [No Abstract]   [Full Text] [Related]  

  • 17. [Regarding the duty of care of a general practitioner for a continuously increasing, elevated PSA level (OLG Koblenz, decision dated 18 June 2015 - 5 U 66/15)].
    Dahm FJ
    Urologe A; 2016 Jul; 55(7):949-51. PubMed ID: 27335093
    [No Abstract]   [Full Text] [Related]  

  • 18. Management of rising prostate-specific antigen following a negative biopsy.
    Jones JS
    Curr Opin Urol; 2010 May; 20(3):198-203. PubMed ID: 20583345
    [No Abstract]   [Full Text] [Related]  

  • 19. Screening for prostate cancer. How can patients give informed consent?
    Marshall KG
    Can Fam Physician; 1993 Nov; 39():2385-90. PubMed ID: 7505673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Xu's chart for prostate biopsy: a visual presentation of the added value of biomarkers to prostate-specific antigen for estimating detection rates of prostate cancer.
    Xu J
    Asian J Androl; 2014; 16(4):536-40. PubMed ID: 24625885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.